The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Leviashvili M.M.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Mishieva N.G.

FGU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdravsotsrazvitiia Rossii, Moskva

Nazarenko T.A.

Kafedra akusherstva, ginekologii, perinatologii i reproduktologii fakul'teta poslediplomnogo professional'nogo obucheniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova;
Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova

Kogan E.A.

Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, Moskva

Leukemia inhibitory factor and endometrial receptivity

Authors:

Leviashvili M.M., Mishieva N.G., Nazarenko T.A., Kogan E.A.

More about the authors

Read: 3154 times


To cite this article:

Leviashvili MM, Mishieva NG, Nazarenko TA, Kogan EA. Leukemia inhibitory factor and endometrial receptivity. Russian Journal of Human Reproduction. 2012;(3):17‑21. (In Russ.)

Recommended articles:

References:

  1. Metkalf D. Int J Cell Clon 1991; 9: 2: 95-108.
  2. Gyul'mamedova I.D., Mezhova O.K. Problemy implantatsii v programme IVF (obzor literatury). Novosti meditsiny i farmatsii 2008; 253: 17-27.
  3. Agadzhanova L.P. Endometrial'nye pinopodii kak markery implantatsii cheloveka (obzor literatury). Probl reprod 2004; 3: 6-11.
  4. Ol'khovskaya M.A. Kompleksnaya otsenka sostoyaniya endometriya v programme EKO: Avtoref. dis. ... kand. med. nauk. M 2007.
  5. Hilton D.J. LIF: lots of interesting functions. Trends Biochem Sci 1992; 17: 2: 72-76.
  6. Ambartsumyan E.M., Agadzhanova L.M. Rol' faktora, ingibiruyushchego leikemiyu, v reproduktsii cheloveka. Akush i gin 2004; 2: 17-21.
  7. Aghajanova L., Skottman H., Stromberg A.M. et al. Uterine receptivity to human embryonic implantation: histology, biomarkers, and transcriptomics. Semin Cell Dev Biol 2008; 19: 2: 204-211.
  8. Sherwin J.R., Smith S.K., Wilson A., Sharkey A.M. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. J Clin Endocrinol Metab 2002; 87: 3953-3960.
  9. Delage G., Moreau J.F., Taupin J.L. In-vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. Hum Reprod 1995;10: 9: 2483-2488.
  10. Laird S.M., Tuckerman E.M., Dalton C.F. The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod 1997; 12: 3: 569-574.
  11. Arici A., Engin O., Attar E., Olive D.L. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 1995; 80: 1908-1915.
  12. Aghajanova L. Update on the role of leukemia inhibitory factor in assisted reproduction. Curr Opin Obstet Gynecol 2010; 22: 3: 213-219.
  13. Lemons A.R., Naz R.K. Contraceptive vaccines targeting factors involved in establishment of pregnancy. Am J Reprod Immunol 2011; 66: 1: 13-25.
  14. Menkhorst E., Zhang J.G. Vaginally Administered PEGylated LIF Antagonist Blocked Embryo Implantation and Eliminated Non-Target Effects on Bone in Mice. PLoS ONE 2011; 6: 519-665.
  15. Dimitriadis E., Nie G., Natalie J. Local regulation of implantation at the human fetal-maternal interface int. J Dev Biol 2010; 54: 313-322.
  16. White C.A., Zhang J.G. Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy. PNAS 2007; 104: 49: 19357-19362.
  17. Ledee-Bataille N., Lapree-Delage G., Taupin J.L., Dubanchet S., Frydman R., Chaouat G. Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Human Reprod 2002; 17: 213-218.
  18. Mikołajczyk M., Skrzypczak J., Szymanowski K. The assessment of LIF in uterine flushing - a possible new diagnostic tool in states of impaired fertility. Reprod Biol 2003; 3: 3: 259-269.
  19. Puri C.P., Katkam R.R. Endometrial contraception: modulation of molecular determinants of uterine receptivity. 2000; 65: 10-11: 783-794.
  20. Mikołajczyk M., Skrzypczak J., Wirstlein P. No correlation between pinopode formation and LIF and MMP2 expression in endometrium during implantation window. Folia Histochem Cytobiol 2011; 49: 4: 615-621.
  21. Mitchell M.H., Swanson R.J., Oehninger S. In vivo effect of leukemia inhibitory factor (LIF) and an anti-LIF polyclonal antibody on murine embryo and fetal development following exposure at the time of transcervical blastocyst transfer. Biol Reprod 2002; 67: 2: 460-464.
  22. Dunglison G.F., Barlow D.H., Sargent I.L. Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium. Hum Reprod 1996; 11: 1: 191-196.
  23. Singh M., Chaudhry P. Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors. J Endocrinol 2011; 210: 1: 5-14.
  24. Stewart C.L., Kaspar P., Brunet L.J. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359: 6390:76-79.
  25. Tsai H.D., Chang C.C., Hsieh Y.Y., Lo H.Y. Leukemia inhibitory factor expression in different endometrial locations between fertile and infertile women throughout different menstrual phases. J Ass Reprod Genet 2000; 17: 415-418.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.